For example, the abnormal activation of the receptor-ligand pairs, DLL3-Notch3, is related to the development of breast cancer, non-small cell lung cancer, and hematological malignancies (Katoh and Katoh, 2020). This evidence concerns the gene DLL3 and breast carcinoma.